Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sutro Biopharma Inc.
Sponsor

Sutro Biopharma Inc.

United States 111 Oyster Point Boulevard, 94080-2037, United States

About the sponsor

Sutro Biopharma Inc. is involved in clinical research for acute myeloid leukemia, with attention to treatment options for infants and children under 12 years of age. The company’s oncology portfolio includes evaluation of luveltamab tazevibulin in this hematologic malignancy.

  • Pediatric AML
  • Luveltamab tazevibulin
  • Hematologic oncology

The sponsor’s work in this area reflects interest in targeted approaches for difficult-to-treat leukemia populations.

About Specializations

Sutro Biopharma Inc. runs clinical trials in conditions such as Neoplasm malignant, Acute myeloid leukaemia, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Neoplasm malignant

Not yet recruiting
Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Sutro Biopharma Inc.

Acute myeloid leukaemia

Not recruiting
InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:0–17 years
  • Substances:Stro-002
  • Sponsor:Sutro Biopharma Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.